JNJ
225.55
+0.06%↑
UNH
364.08
-1.27%↓
TMO
465.22
+0.09%↑
ISRG
452.75
+0.48%↑
ABT
87.25
-1.3%↓
JNJ
225.55
+0.06%↑
UNH
364.08
-1.27%↓
TMO
465.22
+0.09%↑
ISRG
452.75
+0.48%↑
ABT
87.25
-1.3%↓
JNJ
225.55
+0.06%↑
UNH
364.08
-1.27%↓
TMO
465.22
+0.09%↑
ISRG
452.75
+0.48%↑
ABT
87.25
-1.3%↓
JNJ
225.55
+0.06%↑
UNH
364.08
-1.27%↓
TMO
465.22
+0.09%↑
ISRG
452.75
+0.48%↑
ABT
87.25
-1.3%↓
JNJ
225.55
+0.06%↑
UNH
364.08
-1.27%↓
TMO
465.22
+0.09%↑
ISRG
452.75
+0.48%↑
ABT
87.25
-1.3%↓
Ülevaade
Aktsiahinna muutus
24h
Praegune
Min
13.38
Max
13.85
Soovitused | Tugev "osta" hinnang |
|---|---|
12 kuu keskmine prognoos | +201.16% upside |
Järgmine tulemuste avaldamine | 8. mai 2026 |
|---|
Avalo Therapeutics Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Seotud uudised
4. mai 2026, 22:17 UTC
Australia's Westpac Lifts Dividend as 1st Half Profit Rises 2.7%
DJ
Loe
4. mai 2026, 23:47 UTC
Grab Holdings 1Q Adj EBITDA $154.0M Vs. $106.0M >GRAB
DJ
Loe
4. mai 2026, 23:45 UTC
Grab Holdings 1Q Rev $955.0M Vs. $773.0M >GRAB
DJ
Loe
4. mai 2026, 23:45 UTC
Grab Holdings 1Q Net $120.0M Vs. Net $10.0M >GRAB
DJ
Loe
4. mai 2026, 23:40 UTC
Gold Steady Amid Likely Technical Recovery -- Market Talk
DJ
Loe
4. mai 2026, 22:44 UTC
Regis: Jim Beyer To Be Chief Executive of Combined Company
DJ
Loe
4. mai 2026, 22:43 UTC
Regis: Russell Clark To Be Nonexecutive Chairman of Combined Company
DJ
Loe
4. mai 2026, 22:42 UTC
Regis: Companies Expect to Realize Over A$500 Million in Corporate Tax Benefits
DJ
Loe
4. mai 2026, 22:42 UTC
Regis: Combined Company to Have Strong, Debt-Free Balance Sheet; Significant Cash Generation
DJ
Loe
4. mai 2026, 22:41 UTC
Regis: Combined Company to Have Annual Production of More Than 700,000 Oz
DJ
Loe
4. mai 2026, 22:41 UTC
Regis: Pro Forma Market Capitalization About A$10.7 Billion
DJ
Loe
4. mai 2026, 22:40 UTC
Regis: Shareholders to Own About 51% of Combined Company
DJ
Loe
4. mai 2026, 22:40 UTC
Regis: Board Unanimously Endorsed, Supported Deal
DJ
Loe
4. mai 2026, 22:40 UTC
Regis: Deal Unanimously Recommended by Vault Board
DJ
Loe
4. mai 2026, 22:39 UTC
Regis: Vault Shareholders to Receive 0.6947 New Shares in Regis For Each Vault One Held
DJ
Loe
4. mai 2026, 22:38 UTC
Regis Resources to Acquire All Ordinary Shares in Vault
DJ
Loe
4. mai 2026, 22:38 UTC
Regis Resources, Vault Minerals Agree to Merger of Equals
DJ
Loe
4. mai 2026, 22:37 UTC
Palantir Beats Forecasts With $1.63 Billion Quarter as Sales Accelerate -- 2nd Update
DJ
Loe
4. mai 2026, 22:26 UTC
Palantir Beats Forecasts With $1.63 Billion Quarter as Sales Accelerate -- Update
DJ
Loe
4. mai 2026, 22:02 UTC
Australia's Westpac Lifts Dividend as 1H Profit Rises 2.7%
DJ
Loe
4. mai 2026, 22:00 UTC
BOC's Macklem: Conditions To Dictate Fuel-Price Response -- Market Talk
DJ
Loe
4. mai 2026, 21:52 UTC
Westpac 1H Net Profit Ex-Notable Items A$3.48B Vs. A$3.46B>WBC.AU
DJ
Loe
4. mai 2026, 21:50 UTC
Westpac: Some Sectors More Affected Than Others>WBC.AU
DJ
Loe
4. mai 2026, 21:50 UTC
Westpac: Economic Impact of Middle East Conflict to Continue Through Year>WBC.AU
DJ
Loe
4. mai 2026, 21:49 UTC
Westpac 1H Provision for Expected Credit Losses A$4.68B Vs. A$4.58B>WBC.AU
DJ
Loe
4. mai 2026, 21:44 UTC
Westpac 1H Australia Lending Up 8% on Year>WBC.AU
DJ
Loe
4. mai 2026, 21:44 UTC
Westpac 1H Australia Business Lending Up 16% on Year>WBC.AU
DJ
Loe
4. mai 2026, 21:43 UTC
Westpac 1H Core Net Interest Margin 1.78% Vs. 1.80%>WBC.AU
DJ
Loe
4. mai 2026, 21:41 UTC
Westpac 1H Australian Home Lending Up 7% on Year Excluding RAMS Portfolio>WBC.AU
DJ
Loe
4. mai 2026, 21:40 UTC
Westpac 1H Credit Impairment Charge 10 Bps of Average Loans Vs. 6 Bps>WBC.AU
DJ
Loe
Võrdlus sarnastega
Hinnamuutus
Avalo Therapeutics Prognoos
Hinnasiht
By TipRanks
12 kuu keskmine prognoos
Keskmine 41.5 USD 201.16%
Kõrge 52 USD
Madal 29 USD
Põhineb 8 Wall Streeti analüütiku instrumendi Avalo Therapeutics 12 kuu hinnasihil - viimase 3 kuu andmed.
Hinnangu Konsensus
By TipRanks
Tugev "osta" hinnang
8 ratings
8
Osta
0
Hoia
0
Müü
Põhineb 8 analüütiku instrumendi Avalo Therapeutics aktsia reitingul - viimase 3 kuu andmed.
Finantsandmed
$